ABVD: Difference between revisions
Jump to navigation
Jump to search
Created page with "ABVD is the common chemotherapy treatment currently used to treat Hodgkin Lymphoma. ABVD is an acronym for the drugs used in the treatment. A is for Adriamycin (also known as dox..." |
No edit summary |
||
| Line 1: | Line 1: | ||
ABVD is the common chemotherapy treatment currently used to treat Hodgkin Lymphoma. ABVD is an acronym for the drugs used in the treatment. A is for Adriamycin (also known as doxorubicin or hyroxydaunorubicin). B is for Bleomycin. V is for Vinblastine. D is for Dacrbazine. | ABVD is the common [[chemotherapy|chemotherapy]] treatment currently used to treat [[Hodgkin Lymphoma|Hodgkin Lymphoma]]. ABVD is an acronym for the drugs used in the treatment. A is for [[Adriamycin|Adriamycin]] (also known as [[doxorubicin|doxorubicin]] or [[hyroxydaunorubicin|hyroxydaunorubicin]]). B is for [[Bleomycin|Bleomycin]]. V is for [[Vinblastine|Vinblastine]]. D is for [[Dacrbazine|Dacrbazine]]. | ||
Latest revision as of 03:01, 30 October 2015
ABVD is the common chemotherapy treatment currently used to treat Hodgkin Lymphoma. ABVD is an acronym for the drugs used in the treatment. A is for Adriamycin (also known as doxorubicin or hyroxydaunorubicin). B is for Bleomycin. V is for Vinblastine. D is for Dacrbazine.